Clinical and Ultrasonographic Predictors of IUD Related Complications
NCT ID: NCT06806358
Last Updated: 2025-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2025-02-01
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* All participants will be subjected to transvaginal ultrasound to measure uterine size, endometrial and myometrial thickness, uterine position, cervical length, cervical diameter and for detection of any contraindications for IUD insertion.
Power Doppler Energy (PDE) measurement for subendometrial microvascularization will be done and categorized as women with minor subendometrial vascularization (Classifications I and II) and major subendometrial vascularization (Classifications III, IV and V)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association Between Clinical, Laboratory, Ultrasongraphy Predictors And Development of Copper IUD Complications
NCT04178031
Ultrasound Guided Intra-uterine Device Insertion
NCT02393495
Transvaginal Three-Dimensional Ultrasound for Evaluation of Intrauterine Device Position Six Weeks After Insertion
NCT07138248
Uterine Artery Doppler and Menstrual Changes After Insertion Intrauterine Contraceptive Device
NCT05986344
Evaluation of a Novel and Simplified Technique for Intrauterine Contraceptive Devices Insertion: a Prospective Cohort Study
NCT02841826
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
\- All participants will be subjected to transvaginal ultrasound to measure uterine size, endometrial and myometrial thickness, uterine position, cervical length, cervical diameter and for detection of any contraindications for IUD insertion.
Power Doppler Energy (PDE) measurement for subendometrial microvascularization will be done and categorized as women with minor subendometrial vascularization (Classifications I and II) and major subendometrial vascularization (Classifications III, IV and V)
Only clinicians with proven proficiency in IUD insertion will be allowed to perform insertions.
* Perform a bimanual examination to determine the size, shape, and position of the uterus.
* Insert a warm, moistened speculum.
* Cleanse the cervix with an antiseptic solution.
* Open the sterile insertion instruments without touching the inside of the packet and place within easy reach.
* Remove the tenaculum by its handle and grasp the anterior or posterior lip of the cervix. Close gently to the first notch. Having the woman to cough while the tenaculum is being attached can ease the pinch.
* Apply gentle traction with the tenaculum to straighten the canal.
* Remove the sound by its handle and gently insert it to measure the depth of the uterus. Do not apply great force if there is resistance. Apply further traction to the tenaculum and attempt to re-insert the sound at a different angle. Once the sound is inserted and removed, note the depth of the uterine cavity. The woman can expect to feel cramping as the sound is inserted and withdrawn.
* Open the IUD pack without touching its contents.
* Put on sterile gloves.
* Load the IUD and insert it into the uterine cavity according to the manufacturer instructions. As the IUD is inserted through the cervix into the uterus, the patient may have pain and cramping similar to strong menstrual cramps.
* Gently remove the tenaculum. Tamponade any bleeding from the tenaculum site until it is resolved.
* Trim the strings of the IUD to 3-4 cm in length and note the string length. Avoid cutting the strings too short. If the client or her partner becomes aware of the threads, they may be cut shorter in length at the follow-up visit.
* Remove the speculum and assess the woman.
* Pain score will be assessed using Visual Analogue Scale:
1. Anticipated pain or current pain before the intervention.
2. Immediately after speculum insertion.
3. Immediately after tenaculum placement.
4. Immediately after uterine sounding.
5. During or immediately after IUD insertion.
6. Five minutes after the procedure
* Follow up at 3 and 6 months to assess women satisfaction with the method, menstrual pattern, symptoms of vaginal/pelvic infection Abdominal pain/tenderness Dyspareunia (woman/partner) Cramping or pregnancy.
* Vaginal examination to assess any infections or abnormalities and repeat ultrasound examination to assess the position of the IUD
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IUD insertion
IUD insertion in women needing contraception
IUD insertion
* Perform a bimanual examination
* Insert a warm, moistened speculum.
* Cleanse the cervix with an antiseptic solution.
* Open the sterile insertion instruments without touching
* Remove the tenaculum by its handle and grasp the anterior or posterior lip of the cervix.
* Apply gentle traction with the tenaculum to straighten the canal.
* Remove the sound by its handle and gently insert it to measure the depth of the uterus. Do not apply great force if there is resistance. Apply further traction to the tenaculum and attempt to re-insert the sound at a different angle. Once the sound is inserted and removed
* Open the IUD pack without touching its contents.
* Put on sterile gloves.
* Load the IUD and insert it into the uterine cavity according to the manufacturer instructions.
* Gently remove the tenaculum.
* Trim the strings of the IUD to 3-4 cm in length
* Remove the speculum and assess the woman.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IUD insertion
* Perform a bimanual examination
* Insert a warm, moistened speculum.
* Cleanse the cervix with an antiseptic solution.
* Open the sterile insertion instruments without touching
* Remove the tenaculum by its handle and grasp the anterior or posterior lip of the cervix.
* Apply gentle traction with the tenaculum to straighten the canal.
* Remove the sound by its handle and gently insert it to measure the depth of the uterus. Do not apply great force if there is resistance. Apply further traction to the tenaculum and attempt to re-insert the sound at a different angle. Once the sound is inserted and removed
* Open the IUD pack without touching its contents.
* Put on sterile gloves.
* Load the IUD and insert it into the uterine cavity according to the manufacturer instructions.
* Gently remove the tenaculum.
* Trim the strings of the IUD to 3-4 cm in length
* Remove the speculum and assess the woman.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18-25 kg/m2
* Women with any parity seeking contraception and choosing IUD as their preferred method after proper and thorough counseling
* Regularly menstruating women (duration of menstruation 3-7 days and length of cycle 22- 35 days).
* Not using any hormonal therapy or anticoagulation
Exclusion Criteria
* Pregnancy or suspicion of pregnancy
* Congenital or acquired uterine anomalies which distort the uterine cavity (fibroids, endometrial polyps, cervical stenosis, bicornuate uterus, hypoplastic uterus \< 6 cm)
* Acute PID or a history of PID within the past 3 months
* Postpartum or post-abortion endometritis within the past 3 months
* Current STI or within the past 3 months (including cervicitis)
* Cervical cancer
* Endometrial cancer
* Malignant gestational trophoblastic disease
* Undiagnosed vaginal bleeding
* Hypersensitivity to any component in the IUD (copper)
* Less than 6 weeks postpartum.
* Neurological or psychological conditions that may affect pain sensation
20 Years
41 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed M Maged, MD
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Maged
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasr Alainy medical school
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N 362
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.